52
Views
13
CrossRef citations to date
0
Altmetric
Articles

SERUM VEGF AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN HODGKIN LYMPHOMA

, MD, , MD, , PhD & , DSc
Pages 111-115 | Received 23 Jun 2006, Accepted 19 Sep 2006, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Martin S. Staege, Stefanie Kewitz, Toralf Bernig, Caspar Kühnöl & Christine Mauz-Körholz. (2015) Prognostic Biomarkers for Hodgkin Lymphoma. Pediatric Hematology and Oncology 32:7, pages 433-454.
Read now
Myriam Weyl Ben Arush, I. Shafat, Ayelet Ben Barak, Rachel Bar Shalom, Eugene Vlodavsky & Neta Ilan. (2009) PLASMA HEPARANASE AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN CHILDREN WITH HODGKIN LYMPHOMA: Pilot Study. Pediatric Hematology and Oncology 26:4, pages 157-164.
Read now

Articles from other publishers (11)

Poonam Nagpal, Dante B. Descalzi‐Montoya & Niraj Lodhi. (2020) The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV , and exosomes . Cancer Reports 4:2.
Crossref
Lutz Menzel, Uta E. Höpken & Armin Rehm. (2020) Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth. Frontiers in Immunology 11.
Crossref
Jennifer E. Agrusa, Brooks P. Scull, Harshal A. Abhyankar, Howard Lin, Nmazuo W. Ozuah, Rikhia Chakraborty, Olive S. Eckstein, Nitya Gulati, Elmoataz Abdel Fattah, Nader K. El-Mallawany, Rayne H. Rouce, ZoAnn E. Dreyer, Julienne Brackett, Judith F. Margolin, Joseph Lubega, Terzah M. Horton, Catherine M. Bollard, M. Monica Gramatges, Kala Y. Kamdar, Kenneth L. McClain, Tsz-Kwong Man & Carl E. Allen. (2020) Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma. Cancers 12:12, pages 3603.
Crossref
Poonam Nagpal, Mohamed R. Akl, Nehad M. Ayoub, Tatsunari Tomiyama, Tasheka Cousins, Betty Tai, Nicole Carroll, Themba Nyrenda, Pritish Bhattacharyya, Michael B. Harris, Andre Goy, Andrew Pecora & K. Stephen Suh. (2016) Pediatric Hodgkin lymphoma- biomarkers, drugs, and clinical trials for translational science and medicine. Oncotarget 7:41, pages 67551-67573.
Crossref
Ivan S. Moiseev, Sergey V. Lapin, Elena A. Surkova, Margarita Y. Lerner, Vladimir N. Vavilov & Boris V. Afanasyev. (2013) Level of Vascular Endothelial Growth Factor Predicts Both Relapse and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 19:12, pages 1677-1682.
Crossref
Grażyna Sobol, Agnieszka Mizia-Malarz & Halina Woś. (2012) Serum concentrations of proangiogenic cytokines (VEGF, bFGF) depending on the histopathological types of Hodgkin lymphoma in children – preliminary report. Acta Haematologica Polonica 43:4, pages 355-360.
Crossref
Milán GyurkovicsZsolt LohinaiAdrienne GyőrfiIván IványiIbolya SüvegesMária KónyaCsaba BodorAndrea D. SzékelyElek DinyaÁrpád FazekasLászló Rosivall. (2009) Venodilatory Effect of Vascular Endothelial Growth Factor on Rat Gingiva. Journal of Periodontology 80:9, pages 1518-1523.
Crossref
Freda H. Passam, Michael G. Alexandrakis, Maria Kafousi, Marianthi Fotinou, Katerina Darivianaki, George Tsirakis, Paraskevi A. Roussou, Efstathios N. Stathopoulos & Nikolaos M. Siafakas. (2009) Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma. Pathology - Research and Practice 205:1, pages 11-20.
Crossref
Takashi Muramatsu & Hisako Muramatsu. (2008) Glycosaminoglycan-binding cytokines as tumor markers. PROTEOMICS 8:16, pages 3350-3359.
Crossref
Julie Kanter, Samina Y. Khan, Marguerite Kelher, Lia Gore & Christopher C. Silliman. (2008) Oncogenic and Angiogenic Growth Factors Accumulate during Routine Storage of Apheresis Platelet Concentrates. Clinical Cancer Research 14:12, pages 3942-3947.
Crossref
Itay Shafat, Ayelet Ben Barak, Sergey Postovsky, Ronit Elhasid, Neta Ilan, Israel Vlodavsky & Miriam Weyl Ben Arush. (2007) Heparanase Levels Are Elevated in the Plasma of Pediatric Cancer Patients and Correlate with Response to Anticancer Treatment. Neoplasia 9:11, pages 909-916.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.